BioBridge Global 2013 Annual Report
7.1%
BioBridge Global — Organized to maximize our impact In 2013, the South Texas Blood & Tissue Center and its nonprofit sister subsidiaries, QualTex Laboratories, GenCure and The Blood & Tissue Center Foundation, have combined under the auspices of a new nonprofit holding organization – BioBridge Global. We plan to leverage each of the nonprofit subsidiaries’ proven resources through technology and collaboration to build strategic global relationships that position our organization as a world leader in regenerative medicine, cell therapy and biological testing. From humble beginnings, BioBridge Global has risen to meet the critical needs that have propelled our organization to a thriving position in the healthcare industry in our region and beyond.
29.6%
63.3%
Revenue By Source
Client Testing . . . . . . . . . . . . . . . . . . . . . 63.3% Blood & Tissue Processing . . . . . . . . . . 29.6% Other Revenues . . . . . . . . . . . . . . . . . . . . 7.1%
2.9% 4.7%
0.9%
6.1% 12.2%
50.8% 22.4%
Expenses
GenCure Tissue Center
Testing. . . . . . . . . . . . . . . . . . . . . . . . . . . . 50.8% Wages. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22.4% Purchase Services & Other. . . . . . . . . . . 12.2% Supplies. . . . . . . . . . . . . . . . . . . . . . . . . . . . 6.1%
GenCure Cord Blood Center
Benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4.7% Depreciation. . . . . . . . . . . . . . . . . . . . . . . . 2.9% NMDP/ GenCure Cellular Therapy Center
Interest Exp. . . . . . . . . . . . . . . . . . . . . . . . . 0.9%